Stock ONCT ONCTERNAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Oncternal Therapeutics, Inc.

Equities

ONCT

US68236P2065

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-07 EDT 		5-day change 1st Jan Change
8.2 USD -8.79% Intraday chart for Oncternal Therapeutics, Inc. -10.97% -23.54%
05-30 Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of Onct-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer CI
05-09 Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
022249fc9f5ed24a5c6b.E6iDP78hZAm-Sqo6hQUb0w3vwNnAOJUUMeu_yYZHUqA.VcvBe9dLVluLJdsOynJV60iehI-pFex5HNvPgO4lCPhVxPNT6XQLPNgG8w~8a52de211de427dba789c726d07f687c
  1. Stock Market
  2. Equities
  3. ONCT Stock
  4. Charts Oncternal Therapeutics, Inc.
  5. News Chart